Plasma Tumor DNA Biomarkers: Applications and Implications for Breast Cancer TherapyThursday, 19 April 2012 at 11:45 Add to Calendar ▼2012-04-19 11:45:002012-04-19 12:45:00Europe/LondonPlasma Tumor DNA Biomarkers: Applications and Implications for Breast Cancer TherapySELECTBIOenquiries@selectbiosciences.com The identification of somatic genomic alterations present in a patient’s breast cancer allows for the development of DNA biomarkers that are unique for every individual’s tumor. We can assess these DNA biomarkers in the plasma of breast cancer patients by quantitative PCR. This allows us to determine whether the presence or absence of plasma tumor DNA correlates with disease burden, response to therapy and ultimately clinical benefit for the patient. |